Patients with Chronic Lymphocyte Leukemia (CLL) Have Naturally Occurring Antibodies Against the Receptor Tyrosine Kinase (ROR1)

被引：0
|
作者：
Hojjat-Farsangi, Mohammad [1 ]
Mozaffari, Fariba [1 ]
Daneshmanesh, Amir Hossein [1 ]
Osterborg, Anders [2 ]
Shokri, Faze [3 ]
Mellstedt, Hakan [4 ]
机构：
[1] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden
[3] Univ Tehran Med Sci, Dept Immunol, Sch Publ Hlth, Tehran, Iran
[4] Karolinska Inst, Karolinska Univ Hosp, Dept Oncol Radiumhemmet & Hematol, Canc Ctr Karolinska, Stockholm, Sweden
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：773 / 773
页数：1
相关论文
共 50 条
  • [1] Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia
    Hojjat-Farsangi, Mohammad
    Jeddi-Tehrani, Mahmood
    Daneshmanesh, Amir Hossein
    Mozaffari, Fariba
    Moshfegh, Ali
    Hansson, Lotta
    Razavi, Seyed Mohsen
    Sharifian, Ramazan Ali
    Rabbani, Hodjattallah
    Osterborg, Anders
    Mellstedt, Hakan
    Shokri, Fazel
    PLOS ONE, 2015, 10 (11):
  • [2] The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells
    Hojjat-Farsangi, Mohammad
    Khan, Abdul Salam
    Daneshmanesh, Amir Hossein
    Moshfegh, Ali
    Sandin, Asa
    Mansouri, Ladan
    Palma, Marzia
    Lundin, Jeanette
    Osterborg, Anders
    Mellstedt, Hakan
    PLOS ONE, 2013, 8 (10):
  • [3] Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR1) - a Putative Diagnostic Marker for Chronic Lymphocytic Leukemia (CLL).
    Uhrmacher, Sabrina
    Hertweck, Magdalena
    Paesler, Julian
    Erdfelder, Felix
    Filipovich, Alexandra
    Poll-Wolbeck, Simon Jonas
    Razavi, Regina
    Gandhirajan, Rajesh Kumar
    Gehrke, Iris
    Hallek, Michael
    Kreuzer, Karl Anton
    BLOOD, 2009, 114 (22) : 635 - 635
  • [4] Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL)
    Uhrmacher, Sabrina
    Schmidt, Christina
    Erdfelder, Felix
    Poll-Wolbeck, Simon Jonas
    Gehrke, Iris
    Hallek, Michael
    Kreuzer, Karl-Anton
    LEUKEMIA RESEARCH, 2011, 35 (10) : 1360 - 1366
  • [5] Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells
    Daneshmanesh, A. H.
    Hojjat-Farsangi, M.
    Khan, A. S.
    Jeddi-Tehrani, M.
    Akhondi, M. M.
    Bayat, A. A.
    Ghods, R.
    Mahmoudi, A-R
    Hadavi, R.
    Osterborg, A.
    Shokri, F.
    Rabbani, H.
    Mellstedt, H.
    LEUKEMIA, 2012, 26 (06) : 1348 - 1355
  • [6] Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells
    A H Daneshmanesh
    M Hojjat-Farsangi
    A S Khan
    M Jeddi-Tehrani
    M M Akhondi
    A A Bayat
    R Ghods
    A-R Mahmoudi
    R Hadavi
    A Österborg
    F Shokri
    H Rabbani
    H Mellstedt
    Leukemia, 2012, 26 : 1348 - 1355
  • [7] Restricted expression of the orphan tyrosine kinase receptor ROR1 in chronic lymphocytic leukemia
    Carson, DA
    Kipps, TJ
    BLOOD, 2004, 104 (11) : 221A - 221A
  • [8] The receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL) using flow cytometry
    Uhrmacher, S.
    Schmidt, C.
    Hallek, M.
    Kreuzer, K. A.
    ONKOLOGIE, 2011, 34 : 137 - 138
  • [9] T Cells From CLL Patients Recognize Spontaneously Peptides Derived of the Receptor Tyrosine Kinase Ror1
    Hojjat-Farsangi, Mohammad
    Daneshmanesh, Amir Hossein
    Jeddi-Tehrani, Mahmood
    Osterborg, Anders
    Shokri, Fazel
    Mellstedt, Hakan
    Rabbani, Hodjattallah
    BLOOD, 2010, 116 (21) : 1483 - 1483
  • [10] A new class of anti-cancer drugs targeting the tyrosine kinase receptor ROR1 in CLL
    Mellstedt, Hakan
    Khan, Salam
    Hojjat-Farsangi, Mohammad
    Daneshmanesh, Amir Hossein
    Vagberg, Jan
    Bystrom, Styrbjorn
    Schultz, Johan
    Norin, Martin
    Olsson, Elisabeth
    Lofberg, Charlotte
    Norstrom, Carina
    Olin, Thomas
    Tsterborg, Anders
    Moshfegh, Ali
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345